Authors:
Deng, L
Yang, M
Frund, S
Wessel, T
De Abreu, RA
Tischfield, JA
Sahota, A
Citation: L. Deng et al., 2,8-dihydroxyadenine urolithiasis in a patient with considerable residual adenine phosphoribosyltransferase activity in cell extracts but with mutations in both copies of APRT, MOL GEN MET, 72(3), 2001, pp. 260-264
Authors:
Rockwood, K
Mintzer, J
Truyen, L
Wessel, T
Wilkinson, D
Citation: K. Rockwood et al., Effects of a flexible galantamine dose in Alzheimer's disease: a randomised, controlled trial, J NE NE PSY, 71(5), 2001, pp. 589-595
Citation: T. Wessel et al., Determination of purines including 2,8-dihydroxyadenine in urine using capillary electrophoresis, J CHROMAT A, 894(1-2), 2000, pp. 157-164
Authors:
Desimone, M
Kruger, M
Wessel, T
Wehofsky, M
Hoffmann, R
Wagner, E
Citation: M. Desimone et al., Purification and characterization of an aminopeptidase from the chloroplast stroma of barley leaves by chromatographic and electrophoretic methods, J CHROMAT B, 737(1-2), 2000, pp. 285-293
Authors:
Diener, HC
Cortens, M
Ford, G
Grotta, J
Hacke, W
Kaste, M
Koudstaal, PJ
Wessel, T
Citation: Hc. Diener et al., Lubeluzole in acute ischemic stroke treatment - A double-blind study with an 8-hour inclusion window comparing a 10-mg daily dose of lubeluzole with placebo, STROKE, 31(11), 2000, pp. 2543-2551
Authors:
Raskind, MA
Peskind, ER
Wessel, T
Yuan, W
Citation: Ma. Raskind et al., Galantamine in AD - A 6-month randomized, placebo-controlled trial with a 6-month extension, NEUROLOGY, 54(12), 2000, pp. 2261-2268
Authors:
Van Valen, F
Fulda, S
Truckenbrod, B
Eckervogt, V
Sonnemann, J
Hillmann, A
Rodl, R
Hoffmann, C
Winkelmann, W
Schafer, L
Dockhorn-Dworniczak, B
Wessel, T
Boos, J
Debatin, KM
Jurgens, H
Citation: F. Van Valen et al., Apoptotic responsiveness of the Ewing's sarcoma family of tumours to tumour necrosis factor-related apoptosis-inducing ligand (TRAIL), INT J CANC, 88(2), 2000, pp. 252-259